Breaking News Instant updates and real-time market news.

JUNO

Juno Therapeutics

$41.62

-3.59 (-7.94%)

13:05
09/22/17
09/22
13:05
09/22/17
13:05

Juno Therapeutics call volume above normal and directionally bullish

Bullish option flow detected in Juno Therapeutics with 3,856 calls trading, 1.7x expected, and implied vol increasing over 1 point to 63.35%. Oct-17 37.5 puts and Oct-17 45 calls are the most active options, with total volume in those strikes near 1,900 contracts. The Put/Call Ratio is 0.51. Earnings are expected on November 8th.

  • 08

    Nov

  • 22

    Sep

JUNO Juno Therapeutics
$41.62

-3.59 (-7.94%)

08/31/17
STPT
08/31/17
DOWNGRADE
STPT
Reduce
Juno Therapeutics downgraded to Reduce from Buy at Standpoint Research
08/31/17
STPT
08/31/17
DOWNGRADE
STPT
Reduce
Standpoint downgrades Juno after 50% rally in two weeks
Standpoint Research analyst Ronnie Moas downgraded Juno Therapeutics (JUNO) to Reduce from Buy noting that the shares are up more than 50% in the past two weeks. Despite Juno being a takeover target following Kite Pharma's (KITE) agreement this week to be sold to Gilead Sciences (GILD), positions should be trimmed at current share levels, Moas writes in an email. The analyst points out that Juno's market capitalization is over $4B even though no earnings are being generated. The stock in early trading is up 5%, or $1.98, to 42.27.
09/05/17
FBCO
09/05/17
NO CHANGE
FBCO
Outperform
No read through to Gilead, Kite from Cellectis clinical hold, says Credit Suisse
Credit Suisse analyst Alethia Young said the safety issues that Cellectis (CLLS) is encountering, and which prompted a clinical hold be placed on the company's allogenic CAR-T drug, UCART123, could be to some degree related to the company's platform. She adds that CRS, which led to a death in Cellectis' BPDCN study, is a known issue with CAR-T technologies and cases have been seen in Juno (JUNO) and Kite's (KITE) programs as well. The analyst, who doesn't think there is a read through to Kite and Gilead (GILD) from the Cellectis news and remains confident Kite will receive approval later this fall and launch Axi-Cel, keeps an Outpeform rating on Gilead shares.
09/06/17
LEHM
09/06/17
INITIATION
LEHM
Overweight
Juno Therapeutics initiated with an Overweight at Barclays
Barclays initiated Juno with an Overweight rating and a $55 price target, citing Juno's JCAR017 showing promising data with "a potentially better safety profile compared to the KITE/NVS programs," as well as Juno's pipeline having long-term upside.

TODAY'S FREE FLY STORIES

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:39
02/20/18
02/20
08:39
02/20/18
08:39
Earnings
Ecolab raises Q1 adjusted EPS view to 85c-93c from 84c-92c »

Consensus 85c. Ecolab…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

NAVG

Navigators

$59.40

8.7 (17.16%)

08:39
02/20/18
02/20
08:39
02/20/18
08:39
Downgrade
Navigators rating change  »

Navigators downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XENE

Xenon Pharmaceuticals

$3.60

-0.025 (-0.69%)

08:37
02/20/18
02/20
08:37
02/20/18
08:37
Hot Stocks
Xenon Pharmaceuticals initiates Phase 1 clinical trial of XEN901 »

Xenon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHMG

Chemung Financial

$43.90

0.09 (0.21%)

08:37
02/20/18
02/20
08:37
02/20/18
08:37
Upgrade
Chemung Financial rating change  »

Chemung upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$104.78

1.55 (1.50%)

08:36
02/20/18
02/20
08:36
02/20/18
08:36
Hot Stocks
Walmart sees ecommerce losses 'about the same' in FY19 vs. FY18 »

Walmart CFO Brett Biggs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

  • 07

    Mar

HII

Huntington Ingalls

$265.70

10.31 (4.04%)

08:36
02/20/18
02/20
08:36
02/20/18
08:36
Recommendations
Huntington Ingalls analyst commentary  »

Huntington Ingalls price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:35
02/20/18
02/20
08:35
02/20/18
08:35
Earnings
Ecolab sees FY18 adjusted EPS $5.25-$5.45, consensus $5.34 »

The 2018 outlook shown…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:35
02/20/18
02/20
08:35
02/20/18
08:35
Hot Stocks
Genuine Parts reports Q4 sales for Automotive Group up 16.7% »

Fourth quarter sales for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

IMAX

Imax

$22.60

-0.3 (-1.31%)

08:34
02/20/18
02/20
08:34
02/20/18
08:34
Hot Stocks
Imax announces record $35M global debut of Marvel Studios' Black Panther »

IMAX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 05

    Mar

EXPD

Expeditors

$64.12

-0.07 (-0.11%)

08:33
02/20/18
02/20
08:33
02/20/18
08:33
Earnings
Expeditors reports Q4 EPS 92c, consensus 63c »

Reports Q4 revenue $1.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$86.09

0.69 (0.81%)

08:33
02/20/18
02/20
08:33
02/20/18
08:33
Upgrade
Analog Devices rating change  »

Analog Devices upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:32
02/20/18
02/20
08:32
02/20/18
08:32
Earnings
Genuine Parts sees FY18 EPS $5.60-$5.75, consensus $5.93 »

The company is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Earnings
Ecolab reports Q4 adjusted EPS $1.39, consensus $1.39 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

SMP

Standard Motor

$48.20

0.3 (0.63%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Earnings
Standard Motor reports Q4 cont ops EPS 54c, consensus 38c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$172.43

-0.56 (-0.32%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Technical Analysis
Technical Take: Apple slips in early trading »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Earnings
Genuine Parts reports Q4 adjusted EPS $1.19, consensus $1.05 »

Reports Q4 revenue $4.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

GPS

Gap

$33.27

-0.06 (-0.18%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Hot Stocks
Gap announces departure of Gap brand President and CEO Jeff Kirwan »

Gap Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 18

    Mar

ANY

Sphere 3D

$2.33

0.0999 (4.48%)

, FALC

FalconStor

$0.19

0.003 (1.65%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Options
Two option delistings on February 20th »

Option delistings…

ANY

Sphere 3D

$2.33

0.0999 (4.48%)

FALC

FalconStor

$0.19

0.003 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUSHA

Rush Enterprises

$42.77

-0.325 (-0.75%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Recommendations
Rush Enterprises analyst commentary  »

Rush Enterprises price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:29
02/20/18
02/20
08:29
02/20/18
08:29
General news
Stocks point to lower start to week as Walmart weighs on Dow »

Stock futures are…

GOOD

Gladstone

$17.65

0.24 (1.38%)

08:28
02/20/18
02/20
08:28
02/20/18
08:28
Hot Stocks
Gladstone announces sale of Arlington, TX $5.6M »

Gladstone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAN

Aaron's

$43.40

-0.39 (-0.89%)

, LOW

Lowe's

$96.31

-0.2 (-0.21%)

08:28
02/20/18
02/20
08:28
02/20/18
08:28
Recommendations
Aaron's, Lowe's analyst commentary  »

Aaron's Progressive…

AAN

Aaron's

$43.40

-0.39 (-0.89%)

LOW

Lowe's

$96.31

-0.2 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

LVMUY

LVMH

$61.94

0.68 (1.11%)

08:27
02/20/18
02/20
08:27
02/20/18
08:27
Hot Stocks
LVMH names Serge Brunschwig as Chairman and CEO of Fendi »

The LVMH Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$77.27

2.66 (3.57%)

08:26
02/20/18
02/20
08:26
02/20/18
08:26
Earnings
Wabtec reports Q4 adj. EPS 90c, consensus 92c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Mar

ATNX

Athenex

$16.66

-0.11 (-0.66%)

08:25
02/20/18
02/20
08:25
02/20/18
08:25
Hot Stocks
Athenex announces Phase II clinical study results for KX2-391 ointment »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.